Skip to content

Contact Us

On March 17, 2015, Actavis (NYSE:ACT) completed the acquisition of Allergan, creating a $23 billion diversified global pharmaceutical company and a leader in a new industry model - Growth Pharma. The combined company is anchored by strong and sustainable brand franchises, a leading global generics business, a premier pipeline, highly efficient operations and an experienced management team creating an unrivaled foundation for long-term growth. Learn more about this exciting combination at

Actavis Administrative HQ
Morris Corporate Center III
400 Interpace Parkway
Parsippany, NJ 07054
Tel: 862-261-7000

Actavis Investor Relations
Tel: 862-261-7488

Actavis Media Relations
Tel: 862-261-8030

What is your comment or question regarding?